Codex_V5

Mutant	Gene	Virus	Reference
Q167R	UL27	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
L317V	UL27	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
A375T	UL27	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
N498S	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
N498S	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
N498S	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
D515E	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
D515E	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
D515E	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
D542E	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
D542E	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
D542E	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
A543V	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
A543V	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
A543V	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
A786V	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
A786V	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
A786V	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
A928T	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
A928T	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
A928T	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
E949K	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
E949K	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
E949K	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
E949Q	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
E949Q	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
E949Q	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
D981del2	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
D981del2	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
D981del2	UL54	Human betaherpesvirus 5	A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
T400M	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
T400M	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
A543T	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
A543T	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
R570Q	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
R570Q	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
A591V	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
G598A	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
G598A	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
K599N	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
K599N	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
L622M	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
L622M	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
P706S	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
P706S	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
Q381del2	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)
Q381del2	UL97	Human betaherpesvirus 5	Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials. (Sep 2026)